INDOCO REMEDIES
Back to Income Statement
|
INDOCO REMEDIES Last 5 Year Operating Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Operating Profit (Excl OI) | ₹99 Cr | ₹236 Cr | ₹286 Cr | ₹326 Cr | ₹218 Cr |
What is the latest Operating Profit of INDOCO REMEDIES ?
| Year | Operating Profit |
|---|---|
| Mar2025 | ₹99 Cr |
| Mar2024 | ₹236 Cr |
| Mar2023 | ₹286 Cr |
| Mar2022 | ₹326 Cr |
| Mar2021 | ₹218 Cr |
How is Operating Profit of INDOCO REMEDIES Trending?
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹99 Cr | -58.02 | |
| Mar2024 | ₹236 Cr | -17.35 | |
| Mar2023 | ₹286 Cr | -12.32 | |
| Mar2022 | ₹326 Cr | 49.43 | |
| Mar2021 | ₹218 Cr | - | |
Compare Operating Profit of peers of INDOCO REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INDOCO REMEDIES | ₹2,177.8 Cr | -1.3% | 10.3% | -18.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,005.0 Cr | 2.7% | 7.5% | 12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹181,867.0 Cr | 4.2% | 3.9% | 1.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹163,246.0 Cr | 4.3% | 11.2% | 42.5% | Stock Analytics | |
| CIPLA | ₹118,854.0 Cr | 0.4% | 5.3% | -3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,246.0 Cr | 0.9% | 8% | 5.6% | Stock Analytics | |
INDOCO REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INDOCO REMEDIES | -1.3% |
10.3% |
-18.6% |
| SENSEX | 2% |
5.3% |
-6.5% |
You may also like the below Video Courses